Asep Medical Holdings Inc ( $ASEP.C ) is a biotech company that is addressing antibiotic failure by creating peptide technology, and early sepsis detection tech.
Antibiotics are the front-line treatment for sepsis which occurred in 49M people globally in 2017.
But for 23% of these patients, the antibiotics failed which lead to 11 million deaths (19.7% of all deaths in 2017).
$ASEP tech will address this using a novel diagnostic tool that can detect the dysfunctional immune response that underlies the most severe forms of sepsis. This early detection will allow doctors to make better informed life-saving decisions eariler which will add to the efficacy of antibiotics.
Other than the life-saving value of this tech the main reason why I think investing now is a good idea is that clinical testing their tech is already underway and the company intends to file for regulatory approval within the next 6-9 months.
I think that once we could see these filings and eventual approval as huge catalysis for $ASEP.
RN $ASEP is trading at just $0.48/share
https://ca.finance.yahoo.com/news/asep-medical-holdings-inc-announces-133000932.html